Today, Ascelia Pharma AB (publ) (ticker: ACE) (“Ascelia”) announces that it has filed a patent application for a next generation Mangoral pr...
Watch Ascelia Pharma’s presentation at Avanza share day (“börsdag”) 22 May 2019. The presentation can also be downloaded.
On 22 May 2019, Ascelia Pharma’s CEO Magnus Corfitzen will present at the Avanza share seminar (“börsdag”). The presentation will be held at...
Ascelia Pharma AB (publ) (ticker: ACE) today announced that its interim report for the period January-March 2019 is now available on the com...
Ascelia Pharma’s interim report for the period January – March 2019 (Q3 2018/2019) will be published on Wednesday 15 May 2019 at 08:00 CET. ...
Ascelia Pharma AB (publ) (ticker: ACE) today announces that the Nomination Committee in preparation for the Annual General Meeting (AGM) on ...
Ascelia Pharma AB (publ) (ticker: ACE) today announced that the company has completed constructive discussions with the European Medicines A...
During April, the registered number of shares and votes in Ascelia Pharma AB (publ) has increased due to the new issue that was executed in ...
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER...
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER...
